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Abstract
Aims: Elevated expression of cathepsins, integrins and matrix metalloproteinases (MMPs) is
typically associated with atherosclerotic plaque instability. While fluorescent tagging of such
molecules has been amply demonstrated, no imaging method was so far shown capable of
resolving these inflammation-associated tags with high fidelity and resolution beyond micro-
scopic depths. This study is aimed at demonstrating a new method with high potential for
noninvasive clinical cardiovascular diagnostics of vulnerable plaques using high-resolution
deep-tissue multispectral optoacoustic tomography (MSOT) technology.
Methods and results: MMP-sensitive activatable fluorescent probe (MMPSense™ 680) was
applied to human carotid plaques from symptomatic patients. Atherosclerotic activity was
detected by tuning MSOT wavelengths to activation-dependent absorption changes of the
molecules, structurally modified in the presence of enzymes. MSOT analysis simultaneously
provided morphology along with heterogeneous MMP activity with better than 200 micron
resolution throughout the intact plaque tissue. The results corresponded well with epi-
fluorescence images made from thin cryosections. Elevated MMP activity was further confirmed
by in situ zymography, accompanied by increased macrophage influx.
Conclusions: We demonstrated, for the first time to our knowledge, the ability of MSOT to provide
volumetric images of activatable molecular probe distribution deep within optically diffuse tissues.
High-resolution mapping of MMP activity was achieved deep in the vulnerable plaque of intact
human carotid specimens. This performance directly relates to pre-clinical screening applications in
animal models and to clinical decision potential as it might eventually allow for highly specific
visualization and staging of plaque vulnerability thus impacting therapeutic clinical decision making.
Key words: Atherosclerosis, Optoacoustic imaging, Carotid arteries, Plaque, Contrast media,
Inflammation
Abbreviations: CEA carotid endarterectomy; DQ dye-quenched; MSOT multispectral optoa-
coustic tomography; MMP matrix metalloproteinases; OCT optical coherence tomography; CCD
cooled charge-coupled device
Introduction
A
therosclerotic plaque progression is clearly correlated
to increased levels of inflammation [1]. In particular,
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e-mail: czeebregts@hotmail.comthe appearance of matrix metalloproteinases (MMPs),
and especially of MMP-9, in carotid plaque is associated
with high risk vulnerability [2–4]. Even though plaque
anatomy and physiology can be visualized by different
methods such as duplex ultrasound [5], computed
tomography scan [6], magnetic resonance imaging [7]
or intravascular optical coherence tomography (OCT)
[8], imaging of core biological processes involved in
plaque formation on a cellular and molecular level, e.g.,
MMP and protease up-regulation, is limited with these
modalities.
Detection of MMP activity in plaques is possible using
the regular planar fluorescence imaging techniques, assis-
ted with smart activatable molecular probes, e.g.,
MMPSense™ 680 (VisEn Medical, Boston, MA, USA)
[9]. However, due to intense light scattering in tissues as
well as a complicated morphology of common plaques,
the planar fluorescence methods, currently available for
optical imaging, can at best provide a qualitative indica-
tion of the existence of MMP activity rather than an
accurate assessment of its specific location (i.e., three-
dimensional morphology) and distribution. However, if
fluorescence imaging is to be implemented as a diagnostic
clinical tool, it would require ability to three-dimension-
ally image and accurately quantify not only deep seated
plaque anatomy measures but also its physiological and
molecular constitution through several millimeters to
centimeters of tissue.
In the recent study by Levi et al. [10], detection of
optoacoustic signal from a cell culture incubated with
activatable optoacoustic probe, sensitive to enzymatic
cleavage by MMP-2, has been reported. Here, we considered
whether multispectral optoacoustic tomography (MSOT)
[11] could be employed for imaging of atherosclerotic
biomarkers in human carotid arteries by resolving the
activation of previously documented smart probe molecules
specific to enzymes involved in atherosclerosis [12]. Such
ability could then allow the detection of such probes with
unprecedented imaging quality compared to conventional
fluorescence imaging techniques. This is because MSOT has
been recently shown to accurately resolve both intrinsic
tissue morphology along with extrinsically administered
molecular agents [11] and fluorescent proteins [13] deep in
highly scattering biological tissues with spatial resolution
down to around 40 μm, a metric characteristic of diffraction
limited ultrasonic imaging [14]. The technique illuminates
the imaged object using pulsed light at multiple wavelengths
and records the ultrasonic signals generated in response to
light absorption in a tomographic detection setting [11].
Tomographic reconstruction and spectral processing allow
then three-dimensional imaging of tissue chromophores and
extrinsic bio-markers with distinct spectral signatures [15].
In this work we demonstrate that by utilizing the spectral
ability of the technique, absorption changes indicative of
conformational changes of the probe molecules utilized, due to
interaction of the probe molecule with underlying enzymes
present in disease, can be detected and subsequently three-
dimensionally reconstructed with high accuracy.
Methods
Endarterectomy Specimens and Fluorescence
Labeling
Standard surgical carotid endarterectomy (CEA) was performed on
five patients with a symptomatic 970% carotid stenosis at the
University Medical Center Groningen. All investigations con-
formed with the principles outlined in the Declaration of Helsinki.
The freshly isolated CEA specimens were acquired with approval
of the local Ethical Committee and informed consent of the
patients. Immediately after endarterectomy, the plaques were
incubated for 1 h in a 10-μM concentration suspension of MMP-
sensitive activatable probe (MMPSense™ 680; VisEn Medical,
Boston, MA, USA) at 37°C. The control plaques were instead
incubated in PBS for 1 h at 37°C. MMPSense™ 680 is a probe
belonging in a class of activatable ‘smart’ probes that is dark
(minimally fluorescent in its base state) but exhibits fluorescence
properties after conformation changes occurring in the presence
of different enzymes, preferentially MMP2/9 and trypsin and to
a lesser extent of other proteases. Furthermore, once activated,
MMPSense is a potential candidate for optoacoustic imaging
since, similarly to most other far-red and near-infrared fluores-
cent agents and dyes; it has a relatively low quantum yield and
therefore more than 80% of its extinction energy is transferred
into optoacoustic signals. After endarectomy and incubation with
MMPSense the plaque was snap frozen in liquid nitrogen
allowing shipment. Subsequently, it was defrosted and analyzed
by Rotational Planar Fluorescence Imaging and MSOT after
which the specimen was snap frozen again in liquid nitrogen for
further immunohistochemical analysis.
Rotational Planar Fluorescence Imaging
To confirm the presence of activation in the carotid samples
considered, specimens were scanned on a rotational planar
fluorescence imaging system, just before the MSOT imaging.
The samples were placed vertically on a stepper-motor-driven
rotation stage, and were illuminated at 675 nm. Fluorescence
images were collected at multiple angles, after sample rotation in
front of the camera, using an ultra-low noise cooled charge-
coupled device (CCD) camera (VersArray, Roper Scientific,
Trenton, NJ, USA) with a 512×512 pixel array, through a band-
pass fluorescence (710±5 nm; Andover., Salem, NH, USA). The
samples were rotated by 3° steps in the range of 0–360°, each
using an exposure time of 5 s.
Phantom Preparation
Experimental demonstration of the ability to resolve activated
probes by MSOT in a controlled experiment, we prepared and
imaged a phantom moulded from 1.3% of agar powder (Sigma-
Aldrich, St. Louis, MO, USA) into a cylinder of 14-mm diameter.
Tissue-like scattering properties were introduced by mixing 12% of
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cylindrical openings with diameters of approximately 3 mm were
introduced directly into the phantom, both openings containing
MMPSense at 1 μM concentration. The probe in the right opening
was activated using 100 μM Trypsin without phenol red indicator
(Invitrogen, Germany), whereas the probe in the left opening was
incubated with PBS solution only and was in its inactive state.
After 4 h incubation at room temperature, the absorption spectrum
of both the activated and inactive control solution was measured
using a VIS–NIR spectrometer (USB 2000; Ocean Optics,
Dunedin, FL, USA). A planar fluorescence image of the solutions
was recorded to verify probe activation.
Optoacoustic Signal Acquisition
Multiwavelength MSOT experimental setup, shown in Fig. 1, was
based on a tunable MOPO laser (Quanta-Ray MOPO-700; Spectra-
Physics, Mountain View, CA, USA) pumped by a Q-switched Nd:
YAG laser (Quanta-Ray Lab-Series 190–30; Spectra-Physics)
operating at its third harmonic (355 nm). The pulse duration of
the laser was less than 10 ns and the repetition rate is 30 Hz. The
output laser beam size was adjusted to fit the size of the specimen.
The 50/50 beam splitter (BSW16; Thorlabs) splits the beam into
two equal-intensity parts being guided from two opposite directions
onto the object’s surface through two transparent windows in the
imaging tank filled with water. In this way, optimal excitation
conditions close to uniform illumination were achieved. The
estimated light fluence upon the surface of the specimen was
2 mJ/cm
2, a level well below the permissible exposure limit [16]o f
20 mJ/cm
2 at the wavelength range used here for the imaging. A
wideband piezoelectric PZT transducer (V319, 3.5 MHz central
frequency, Panametrics-NDT UT Transducers, Olympus) was used
to detect optoacoustic signals from the illuminated sample. The
transducer was cylindrically focused in the imaging plane (38 mm
focal distance) to allow 3D data acquisition via vertical scanning.
Two 45° tilted mirrors were used to change the beam height by
moving the bottom mirror with a vertical translation stage. The
beam splitter and the ultrasonic transducer were translated by the
same stage, thus both the illumination and detection planes were
translated simultaneously to allow for 3D image acquisition via
vertical scanning. The samples were mounted on a rotational stage
so that in-plane tomographic data acquisition was done by 360°
rotation of the sample. A 14-bit resolution PCI digitizer with a
sampling rate of 100 MS/s (NI PCI-5122; National Instruments,
Austin, TX, USA) was used to record the time-resolved acoustic
signals detected by the transducer. We placed a photodiode
(FDS010, 200–1100 nm, 1 ns Rise Time; Thorlabs) in the
vicinity of the laser output window and recorded the intensity
change of scattered light for each pulse in order to normalize the
detected signals for laser output instabilities. In this way,
quantitative readings of pulse-to-pulse laser intensity variations
over broad wavelength range were obtained by calibrating the
measurements using spectral response curve of the diode. This
continuous power monitoring was of critical importance for
multispectral reconstructions since some of important biomarkers
may present only a small variation of the optical absorption over
highly absorbing background, in which case even small
quantification inaccuracies may lead to flawed results. The laser,
stage controllers, and data acquisition were all synchronized via
Labview-based interface (National Instruments). Single-wave-
length two-dimensional data acquisition took approximately
30 s. Generation of a full 3D data set with, e.g., three
wavelengths and ten vertical slices would take about 20 min.
Image reconstruction for each vertical slice required 3 s and was
performed by using a two-dimensional filtered back-projection
(cylindrical Radon) algorithm [17].
Multispectral Optoacoustic Tomography
and Detection of Enzymatic Activation
MSOT can distinguish the activated probe, over both slowly
varying spectra of the background and the inactive probe, by
acquiring optoacoustic data at several wavelengths and analyzing
spectral contributions on a per-pixel bases, i.e.,
 a
j l ðÞ ¼ "a l ðÞ ca
j þ "i l ðÞ ci
j þ B l ðÞ ð 1Þ
where  a
j l ðÞis wavelength-dependent absorption in pixel j
as reconstructed by optoacoustic tomography, B(l)i s
contribution of background chromophores, εa(l), εi(l), ca
j,
and ci
j are extinction of activated and inactive probe and
their spatial distribution on a per pixel basis. Probe
distribution (both activated and inactive) can subsequently
be found by, e.g., applying linear regression to Eq. 1 at
multiple wavelengths. However, in the particular case
studied here, we observed that inactive MMPSense
exhibits similar absorption (extinction) at 635 and
675 nm, i.e., εi (675)≈εi (635). By further assuming slow
Fig. 1. Schematics of the multispectral optoacoustic
tomography (MSOT) experimental setup.
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explicit expression for the activated probe distribution
ca
j ¼
 a
j 675 ðÞ    a
j 635 ðÞ
"a 675 ðÞ   "a 635 ðÞ
¼
  
 "
ð2Þ
leading to an effective suppression of the contribution from
the inactive probe. Distribution of the latter can also be
resolved using a similar procedure. Nevertheless, it is
presumed that in more complicated cases, especially in the
presence of high background variations of whole blood in
living tissues, true multispectral fitting procedures (using full
version of Eq. 1 including known spectra of blood) might
become necessary for effective background suppression.
Cryosectioning and Epi-Fluorescence Imaging
Immediately following the MSOT and fluorescence imaging
session, the agar-embedded specimen was placed into a 30 mm
∅ syringe (Falcon, Becton Dickinson, Franklin Lakes, NJ, USA)
and freezing medium was added. The syringe and its content were
snap-frozen at −80°C. After freezing, cryosections through the
entire sample were made with 50-μm intervals. For every 1 mm, the
thickness of the sections was reduced to 10 μm providing sections
suitable for additional histological analysis. Selective 50-μm
sections (approx. every 1 mm) were imaged by an epi-fluorescence
method to attain scattering-free images of fluorescence activity in
each thin section.
In Situ Zymography
In order to confirm presence of active MMPs in areas with
increased fluorescence, as identified by MSOT, a cryosection
(10 μm) from the corresponding area was subjected to in situ
zymography to visualize gelatinase activity. To this end, the section
was incubated with DQ™ gelatin (100 μg/mL, EnzCheck®
Gelatinase/Collagenase Assay Kit; Invitrogen-Molecular Probes,
Breda, the Netherlands) dissolved in 1% agarose (in PBS, Type IX,
Ultra-low Gelling Temperature, Sigma-Aldrich Chemie, Zwijndrecht,
the Netherlands) overnight at 37°C. 4′,6-Diamidino-2-phenylindole
dihydrochloride (DAPI) was added to the 1% agarose solution to stain
nuclei. To control for autofluorescence, a serial section was incubated
with 1% agarose/PBS/DAPI in the absence of DQ™ gelatin. Sections
were analyzed on a Leica DMLB fluorescence microscope (Leica
Microsystems, Rijswijk, the Netherlands) equipped with a Leica
DC300F camera and LeicaQWin 2.8 software.
Immunohistochemistry for CD68
Cryosections (10 μm) from areas with differential MMP activity as
identified by MSOT and in situ zymography were analyzed for the
presence of infiltrated CD68
+ macrophages using immunohisto-
chemistry. Frozen sections were thawed, air-dried and then acetone-
fixed for 10 min at room temperature. After fixation, sections were
air-dried followed by endogenous peroxidase blockade (0.3% H2O2
in PBS, 15 min room temperature). Next, sections were rinsed in
PBS and blocked in 10% rabbit serum/1% BSA/PBS for 15 min.
After blocking endogenous avidin/biotin (Avidin/Biotin blocking
kit; Vector Laboratories, Burlingame, CA, USA) the sections were
incubated with mouse-anti-human CD68 (clone KP1; DAKO
Netherlands, Heverlee, Belgium) in 1% BSA/PBS for 60 min,
room temperature. Following primary antibody incubation, sections
were rinsed in PBS (3×5 min) after which they were incubated with
biotin-conjugated rabbit-anti-mouse polyclonal antibody (DAKO)
in 1% BSA/PBS for 30 min, room temperature. After rinsing in
PBS (3×5 min) sections were incubated with HRP-conjugated
streptavidin (DAKO) for 30 min, room temperature. Peroxidase
activity was visualized with 3-amino-9-ethylcarbazole (AEC).
Nuclei were counterstained with hematoxylin and sections were
embedded in Kaiser’s glycerin–gelatin. Sections were analyzed on
an Olympus BX50 microscope (Olympus Nederland, Zoeterwoude,
the Netherlands) equipped with an Olympus DP70 camera and Cell
B imaging software.
Results
Phantom Validation Studies
Figure 2 demonstrates basic validation measurements that
summarize and explain the MSOT ability to detect probe
enzymatic activation. Fig. 2a plots measurements of the
spectral extinction characteristics of the inactive (dotted line)
and activated (solid gray line) forms of the MMPSense™
680 probe while the spectra of oxy- and deoxyhemoglobin is
also shown for reference purposes. An enabling feature for
the method developed herein, is the characteristic spectral
change of the extinction (absorption) coefficient between
activated and non-activated states, in the far-infrared portion
of the spectrum between 635 and 675 nm, shown in greater
detail in the insert of Fig. 2a.
To test the methodology, the tissue-mimicking (scattering
and absorbing) phantom with insertions containing activated
and inactive MMPSense probe was imaged by both MSOT and
epi-fluorescence. While spectral changes between active (cir-
cular insertion on the right) and inactive (insertion on the left)
are not clearly distinguishable at the representative single
wavelength reconstructions of Fig. 2b (made at 635 nm) and
Fig. 2c (675 nm) of the phantom imaged, multispectral
processing accurately reveals the different states between the
left and right tubes in Fig. 2d.F i g .2es h o w sac o r r e s p o n d i n g
‘top-view’ planar fluorescence image of the phantom, made
after the MSOT measurements, showing strong fluorescence
from the insertion containing the activated probe. Interestingly,
light diffusion through the phantom causes the appearance of
background diffusive fluorescence signal on Fig. 2e,w h i c hi s
absent from the reconstructed MSOT images of Fig. 2d due to
the high-resolution three-dimensional imaging capabilities of
the method, not affected by light diffusion. Finally, Fig. 2f
offers an independent confirmation of the MMPSense activa-
tionby trypsin and thefluorescence signalchangesobserved by
direct imaging of activation in two transparent tubes, without
surrounding diffusive medium.
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Fluorescence
Figure 3b–d presents rotational images taken from a
representative intact plaque sample (shown in Fig. 3a), from
different view angles. Normally, MMP (fluorescence)
activity should be mostly concentrated around the carotid
artery bifurcation area, where most of the vulnerability is
expected [18]. However, common plaques represent geo-
metrically complex and highly heterogeneous structures,
having multiple openings and large variations in vessel wall
thickness and optical properties of different components.
The multiple projection images and the rotational movie
(available as Supplementary Information online) evince that
the excitation and emission light have been guided and
attenuated non-uniformly in various areas of the plaque. This
readily leads to erroneous conclusions regarding the origin
of the fluorescent signals that are being detected by the CCD
camera located outside the sample and in any case does not
allow for a three-dimensional understanding of the disease
extent. As an example, some of the light in Fig. 3d, that is
thought as coming from the opening of the external carotid
(branch) artery, could in fact originate from another location
deep inside the plaque and guided through scattering-free
areas. In another projection, shown in Fig. 3c, the bifurcation
area does not show high levels of fluorescence. The likely
explanation for this observation is that the branch artery is
located relatively far away from the surface that is facing the
CCD camera resulting in high attenuation of the light as it
travels through a highly scattering and absorbing plaque
area. The inaccuracy of planar fluorescence imaging has
been previously discussed [19].
Figure 3e shows three-dimensional morphological optoa-
coustic images resulting from an intact plaque. These data are
obtained at a single wavelength of 635 nm at which activated
MMPSense has low excitation efficiency so that mostly
morphological information but not MMP activity can be
extracted from the images. The morphologic characteristics
have in-plane resolution on the order of 200 μm, limited by the
useful bandwidth of the ultrasonic detector. Images at four
different levels around the bifurcation area, all separated by
2 mm, are shown, revealing good correspondence to the color
photographs of a sliced plaque (Fig. 3f). The 50-μm
cryosections were obtained approximately from the same area
where optoacoustic images were produced.
Three-Dimensional Visualization of MMP Activity
from an Intact Specimen with MSOT
In order to resolve MMP activity with high-resolution over
non-specific intrinsic tissue background and inactive probe
Fig. 2. a Measured spectral extinction characteristics of inactive (dotted line) versus activated (solid gray line) MMPSense™
680 probe. Spectra of oxy- and deoxyhemoglobin are also shown for reference. Inset: zoom-in from the wavelength range that
was used for MSOT imaging. b Optoacoustic image of phantom with MMPSense™ insertions at 635 nm excitation. Circular
insertion containing activated probe is on the right while the inactive insertion is on the left. c Corresponding optoacoustic
image at 675 nm excitation. d Multispectrally resolved (MSOT) image resolving the distribution of activated probe inside the
phantom. e Planar (top view) fluorescence image of the phantom performed after MSOT imaging sessions, confirming
fluorescence from the activated probe. f Planar fluorescence image comparing inactive (left) and active MMPSense™.
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viously described in the phantom section. The results in
Fig. 4 are shown for three representative specimen, two
MMPSense-incubated and one control plaque. Panels a, b
and c show cross-sectional MSOT reconstructions, clearly
revealing an intra-plaque area with increased signal referred
to as ‘hot spots’ (shown in green), superimposed onto
morphological optoacoustic images (made using single 635-
nm wavelength). The hot spots are characterized by
increased MMP activity as the spectrally resolved MSOT
signal originates only from the activated MMPSense™ 680.
For validation, epi-fluorescence images of dissected plaque
(50-μm sections), superimposed on the corresponding color
photographs (panels d, e and f), were done at approximately
the same level and match well the corresponding MSOT
results. Both MSOT analysis performed on whole activated
specimens as well as epi-fluorescence performed on cry-
osections thus revealed the highest level of MMP activity
close to the bifurcation area of the carotid artery. Corre-
spondingly, both MSOT analysis and epi-fluorescence
images made on the control specimen did not show
fluorescence activity (panels c and f, respectively).
Histopathology
In order to confirm the MSOT data showing differential
MMP activity within an atherosclerotic plaque area, addi-
tional histological analyses were performed on the plaque
shown in Figs. 3 and 4(b and e). First, in situ zymography
was performed on 10-μm cryosections to visualize presence
of active gelatinases, i.e., MMP’s able to degrade gelatin.
Based on the MSOT and epi-fluorescence data, two regions
of interest were selected based on the presence (denominated
as a ‘hot-spot’) or relative absence (denominated as ‘cold-
spot’) of the signal (marked in Fig. 5a with blue and white
frames, respectively). Incubation with dye-quenched (DQ)
Fig. 3. Rotational planar fluorescence imaging of an intact
specimen and plaque morphology. a Color image of a human
carotid specimen. b–d Fluorescence images from the same
specimen embedded in clear agar phantom rotated with 90°
steps. See also Video online of continuously rotated speci-
men. e Three-dimensional stack (2-mm vertical steps) of
morphological optoacoustic images made from an intact
specimen using 635 nm illumination. f The corresponding
color images from dissected plaque.
Fig. 4. Localization of MMP activity in three carotid speci-
men. Samples 1 and 2 were incubated in MMPsense 680
while sample 3 (control) was incubated in PBS. a–c Imaging
results from intact plaques made with MSOT. Cross-sec-
tional multispectral reconstruction, revealing location of
MMPSense 680 activity in the slice, is shown in green color
that is superimposed onto morphological optoacoustic
images (made using single 635-nm wavelength). As
expected, samples 1 and 2 show fluorescence from the
activated MMPSense, while the control sample has no
fluorescence signal. d–f The corresponding epi-fluorescent
images from dissected plaque (in green) superimposed onto
color images of cryosections from the three carotid plaque
specimen. The images were done approximately at the same
level as in MSOT sessions in (a)–(c).
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gelatinase activity in the ‘hot-spot’ area (b) compared with
the ‘cold-spot’ area (c). Within the ‘hot-spot’, active MMPs
were primarily extracellularly located. Within the ‘cold-spot’
area, active MMP’s were detected which were, however,
primarily located within the vascular media (c). Although
some fluorescence was detected within the plaque area of the
‘cold-spot’, this is most likely the result of autofluorescence
since after incubation in the absence of DQ-gelatin fluo-
rescence was still detected (e). The autofluorescence is
probably derived from necrotic cell debris and calcified
fragments as also suggested by the aberrant nuclear staining
pattern with DAPI and absence of nuclei with normal
morphology (c, e). In the ‘hot-spot’ area autofluorescence
was virtually absent (d).
In addition to zymography, we subsequently analyzed
whether enhanced MMP activity was associated with an
increased macrophage influx. Fig. 5f–h shows the region of
interest containing both the ‘hot-spot’ and ‘cold-spot’ areas.
The region of interest presented with a heterogeneous
macrophage infiltration pattern, most macrophages being
concentrated in the ‘hot-spot’ area (f). Higher power
magnifications revealed massive macrophage influx in the
‘hot-spot’ area (g), whereas the ‘cold-spot’ area was almost
devoid of macrophages (h). These data suggest and confirm
observations by others [1, 12] that infiltrating macrophages
are the main producers of MMP’s thereby contributing to
plaque vulnerability.
Discussion
The indication for a CEA is currently largely based on the
combination of symptomatology and degree of stenosis
(970%), as defined by flow measurements with duplex
ultrasound. These parameters, however, do not provide an
accurate assessment of plaque vulnerability and therefore
Fig. 5. ‘Hot spot’ area identified by MSOT (blue frame in a) is characterized by increased gelatinase activity and CD68
+
macrophage influx. In situ zymography and immunohistochemistry for CD68 were performed on 10-μm cryosections
corresponding to the area that revealed enhanced MMP activity as identified by MSOT. b, c Images from cryosections
incubated with dye-quenched (DQ) gelatin on the ‘hot spot’ and ‘cold spot’ areas, respectively. To check for the presence of
autofluorescence, cryosections were also incubated in the absence of DQ gelatin and ‘hot spot’ (d) and ‘cold spot’ (e) areas
were analyzed. Nuclei were stained with DAPI. Original magnifications: B–E: ×160; insets in B–E: ×640. The CD68 expression in
the entire region of interest, indicated by the dotted frame in (a), is shown in (f), where both the ‘hot spot’ area (blue frame) and
‘cold spot’ area (white frame) were identified. The ‘hot spot’ area was characterized by massive macrophage infiltration (g)
compared with the ‘cold spot’ area (h). Insets (g, h): high-power magnifications. Original magnifications: B, ×20; C–D, ×40;
insets in C–D, ×200.
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the surgical intervention by preventing a major cerebrovas-
cular event, especially in the asymptomatic group [20, 21].
Indeed, introduction of fluorescent molecular probes,
sensitive to plaque vulnerability, has proven to provide a
generally good indication of the existence of inflammatory
processes. Nonetheless, volumetric fluorescence imaging of
plaque activity was so far limited by high degree of
scattering in large tissue volumes [9, 22], which makes it
difficult to accurately localize, quantify and characterize the
morphology of the plaque and its vulnerability.
In this report, we have shown that MSOT can resolve
with high specificity activated proteases, by using the
corresponding absorption changes of activatable ‘smart’
probes. It can further deliver high-resolution images of
activated probes within tissue, herein an optically scattering
human carotid specimen. This newly detected capability was
found useful in characterizing plaque formations in athero-
sclerotic disease. Optoacoustic images can simultaneously
show the underlining plaque morphology for accurate
localization of MMP activity in three dimensions. Further-
more, the MSOT method can simultaneously provide maps
of both activated and inactive probe distribution, thus,
provide information on molecular contrast and probe
biodistribution without introduction of additional blood pool
agent. Our future studies will aim at imaging several
different probes optimized for different targets. This could
potentially be done by using two probes with peak
absorption at say 750 and 680 nm and acquiring multi-
wavelength optoacoustic data in the spectral windows
around 680 and 750 nm. This, however, will certainly
require multiple (more than two) wavelengths for efficient
spectral unmixing of both probes.
The MSOT findings were verified with a panel of
confirmatory studies, i.e., epi-fluorescence imaging of
cryosections, zymography and immunohistochemistry. The
results from the zymography and immunohistochemistry
clearly show a correspondence of MSOT signals and the
underlying levels of inflammatory activity, macrophage
influx and MMP activity. Results from both MSOT
investigations and histological sections confirmed that most
of the plaque formation activity occurs, as expected, close to
the bifurcation area of the carotid artery.
Even though the current study has dealt with proving the
basic feasibility of molecular and morphological character-
ization of plaques by MSOT, we are currently seeking after
in vivo implementation of the method. Here, the presence of
blood will introduce additional absorption of light, which
will also become more spectrally dependent. This, in turn,
will necessitate more sophisticated light attenuation correc-
tion and spectral processing algorithms, which take into
account absorption spectra of oxy- and deoxyhemoglobin.
Some of those issues could potentially be addressed using
blind unmixing methods [23]. Moreover, even though the
current MSOT imaging geometry has been proven success-
ful for whole-body imaging of living mice [24, 25], clinical
translation of the suggested methodology might involve a
different technical implementation in terms of light delivery
and ultrasonic detection arrangement. This is because most
regions of interest in the human body might only be
accessible from one side and no full tomographic geometry
is available.
Overall, optoacoustics is an inherently three-dimen-
sional visualization tool that has already proven to be
capable of penetrating several centimeters into large
animals and humans [11, 15], thus it can potentially
image carotid arteries noninvasively. Furthermore, the
spatial resolution of the method is not affected by degree
of scattering; thus, it can deliver high-quality data from
large diffuse tissue volumes, not accessible by other
optical imaging techniques. We therefore foresee our
MSOT method to be eventually implemented as a
noninvasive diagnostic tool for accurate detection and
characterization of cardiovascular disease and biomarker
activity, e.g., for in vivo staging of carotid plaque
formations for future clinical decision-making.
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